Tokyo Study Group Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
1996
NCT00232375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1996

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

insulin human (humulin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1